Latest Biological therapy for inflammatory bowel disease Stories
BRUSSELS, May 10, 2011 /PRNewswire/ -- UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology.
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive.
NEW YORK (Reuters Health) - Treatment of moderate-to-severe active ulcerative colitis, a severe inflammatory disease of the colon, with the drug infliximab is associated with sustained clinical responses and intestinal healing, according to results of two studies reported in The New England Journal of Medicine.
According to two studies published today in the American Gastroenterological Association (AGA) journal Gastroenterology, people with inflammatory bowel disease are more prone to developing severe disorders of the respiratory and nervous systems. The studies found an increase in the prevalence of asthma, arthritis, chronic renal disease, multiple sclerosis and psoriasis, among other disorders.
- Withering but not falling off, as a blossom that persists on a twig after flowering.